AzTrials
AzTrials

HealthyBGINCT02616276

Postprandial Effect of Breakfast Glycemic Index on Vascular Function, Insulinemia and Cognitive Performance (BGI Study)

A study testing High glycemic index breakfast and Low glycemic index breakfast in people with Healthy, run by Fundacion para la Investigacion y Formacion en Ciencias de la Salud at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a crossover clinical trial aimed at adults (aged 20-40 years, with no cardiovascular disease), selected by consecutive sampling at urban primary care health clinics in Salamanca (Spain). Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
High glycemic index breakfast and Low glycemic index breakfast
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
Dec 2015to Feb 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Young adults.
  • Aged between 20 and 40 years.
  • Both sexes.
  • Those agree to sign the informed consent.

Who cannot join

  • History of cardiovascular events (acute myocardial infarction, stroke, etc.).
  • History of hypertension, diabetes mellitus or dyslipidemia.
  • Pharmacological treatment for any of the above conditions.
  • Diagnosis of clinically demonstrable neurological and/or neuropsychological disease.
  • Excessive consumption of toxic substances.
  • Celiac patients and/or those intolerant to lactose.
Show all 9Show fewer
  • Subjects on a low-calorie and/or low-sodium diet.
  • Pregnant women.
  • Those with any other circumstance that the investigators consider could interfere with the study procedures.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Primary Care Research Unit - The Alamedilla Center for Health

    Salamanca, Salamanca, 37003

Other trials in Spain

About this study

Official title: Postprandial Effect of Breakfast Glycemic Index on Vascular Function, Insulinemia and Cognitive Performance, a Crossover Clinical Trial (BGI Study)

This is a crossover clinical trial aimed at adults (aged 20-40 years, with no cardiovascular disease), selected by consecutive sampling at urban primary care health clinics in Salamanca (Spain). Each subject will complete three interventions, with a washout period of one week: control breakfast (water), low glycemic index breakfast (apple, yogurt, walnuts and black chocolate) and high glycemic index breakfast (grape juice, bread and strawberry jam). The postprandial effect will be assessed at 60 and 120 minutes from each breakfast, measuring blood glucose and insulin and cognitive performance. Measurements will be performed of central blood pressure, augmentation index, pulse wave velocity, cardiac output and total peripheral vascular resistance at minutes (-10, 0, +15, +30, +45, +60, +75, +90, +105 and +120).

Read the detailed description

Objectives:

The primary objective of this study is to evaluate the postprandial effect of low and high glycemic index breakfasts on vascular function, measured by central blood pressure, augmentation index and pulse wave velocity, in a sample of healthy young adults. The second objective is to assess the postprandial effect of low and high glycemic index breakfasts on blood glucose and insulin values in a sample of healthy young adults. The third and last objective is to assess the postprandial effect of low and high glycemic index breakfasts on cognitive performance in a sample of healthy young adults.

Design and setting:

A controlled crossover clinical trial, where each subject will complete three interventions (control breakfast, high glycemic index breakfast and low glycemic index breakfast), with a washout period of one week between each, and whose order will be determined by a randomization sequence generated using the Randomization.com software (http://www.randomization.com).

Study setting:

The study will be conducted in the primary care health area of Salamanca in the Research Unit of La Alamedilla, belonging to the Spanish Network for Preventive Activities and Health Promotion (redIAPP) and Salamanca Institute for Biomedical Research (IBSAL).

Study population:

The subjects of the study population will be selected by consecutive sampling in the primary care clinics of urban health centers in Salamanca (Spain) between 2015 and 2016. As this crossover clinical trial, a consecutive sampling will ensure comparability of the groups.

Intervention:

Each of the three scheduled visits will last approximately 2 and a half hours, and will be structured as follows:

Min -10: Measurement of clinical blood pressure, central blood pressure, and central hemodynamic parameters; evaluation of cognitive performance; laboratory test sampling to determine glucose and insulin blood levels.

Min 0: Measurement of central blood pressure and central hemodynamic parameters; intake of assigned breakfast (10 minutes).

Min +15, +30, +45: Measurement of central blood pressure and central hemodynamic parameters.

Min +60: Measurement of central blood pressure and central hemodynamic parameters; evaluation of cognitive performance; laboratory test sampling to determine glucose and insulin blood levels.

Min +75, +90, +105: Measurement of central blood pressure and central hemodynamic parameters.

Min +120: Measurement of central blood pressure and central hemodynamic parameters; evaluation of cognitive performance; laboratory test sampling to determine glucose and insulin blood levels.

Conditions
Healthy
Being tested
Control breakfast, High glycemic index breakfast, Low glycemic index breakfast
Keywords
Glycemic Index, Postprandial Period, Vascular Stiffness, Blood glucose, Cognition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control breakfastOther

    Also called BF-1

    It consists of 350 ml of water at room temperature.

  • High glycemic index breakfastOther

    Also called BF-2

    It consists of 350 ml of water at room temperature, 200 ml of grape juice (with 136.28 kcal), 40 g of white bread (2 slices of 52.2 kcal each) and 29 g of strawberry jam (with 127.52 kcal); providing a total of 368.2 kcal.

  • Low glycemic index breakfastOther

    Also called BF-3

    It consists of 350 ml of water at room temperature, a 150 g apple (with 81.12 kcal), a 125 g low-fat natural yogurt (with 56.10 kcal), 3 shelled walnuts (with 38.94 kcal per unit) and 17.5 g of 72% black chocolate (with 102 kcal); supplying a total of 356.04 kcal.

Study groups in NCT02616276
Study groupRoleWhat they receive
ControlActive comparatorControl breakfast
Receives: Other: Control breakfast; Other: High glycemic index breakfast; Other: Low glycemic index breakfast
Intervention 1ExperimentalHigh glycemic index breakfast
Receives: Other: Control breakfast; Other: High glycemic index breakfast; Other: Low glycemic index breakfast
Intervention 2ExperimentalLow glycemic index breakfast
Receives: Other: Control breakfast; Other: High glycemic index breakfast; Other: Low glycemic index breakfast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Augmentation index

    Measurement by Mobil-O-Graph® device

    Measured: Changes in augmentation index at 1 week, according to glycemic index of the breakfast

Secondary outcomes (13)
  1. Central blood pressure

    Measurement by Mobil-O-Graph® device

    Measured: Changes in central blood pressure at 1 week, according to glycemic index of the breakfast

  2. Pulse wave velocity

    Measurement by Mobil-O-Graph® device

    Measured: Changes in pulse wave velocity at 1 week, according to glycemic index of the breakfast

  3. Blood glucose

    Measurement by laboratory test sampling

    Measured: Changes in blood glucose at 1 week, according to glycemic index of the breakfast

  4. Insulin values

    Measurement by laboratory test sampling

    Measured: Changes in insulin values at 1 week, according to glycemic index of the breakfast

  5. Immediate verbal memory

    Assessment by immediate recall of a list of 15 words, in three attempts

    Measured: Changes in immediate verbal memory at 1 week, according to glycemic index of the breakfast

  6. Delayed verbal memory

    Assessment by free recall of the words learnt in the first part of the study after a period of approximately 10 minutes

    Measured: Changes in delayed verbal memory at 1 week, according to glycemic index of the breakfast

  7. Phonological fluency

    Assessment by enumerating for one minute as many words as possible starting with different letters

    Measured: Changes in phonological fluency at 1 week, according to glycemic index of the breakfast

  8. Attention

    Assessment by Trail Making Test A

    Measured: Changes in attention at 1 week, according to glycemic index of the breakfast

  9. Processing speed

    Assessment by Trail Making Test B

    Measured: Changes in processing speed at 1 week, according to glycemic index of the breakfast

  10. Executive functions

    Assessment by Trail Making Test B

    Measured: Changes in executive functions at 1 week, according to glycemic index of the breakfast

  11. Working memory

    Assessment by WAIS Digit Span Backward test

    Measured: Changes in working memory at 1 week, according to glycemic index of the breakfast

  12. Sustained attention

    Assessment by Stroop test

    Measured: Changes in sustained attention at 1 week, according to glycemic index of the breakfast

  13. Selective attention

    Assessment by Stroop test

    Measured: Changes in selective attention at 1 week, according to glycemic index of the breakfast

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2015 (estimated)
  2. Study startDec 2015
  3. Primary completionJun 2016
  4. Study completionFeb 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02616276
Sponsor's protocol ID
GRS 1192/B/15
Acronym
BGI
Status last verified
Mar 2017
First submitted
19 Nov 2015
Last updated
17 Mar 2017
Results posted
No
Data monitoring committee
No

Publications

  • Sanchez-Aguadero N, Garcia-Ortiz L, Patino-Alonso MC, Mora-Simon S, Gomez-Marcos MA, Alonso-Dominguez R, Sanchez-Salgado B, Recio-Rodriguez JI. Postprandial effect of breakfast glycaemic index on vascular function, glycaemic control and cognitive performance (BGI study): study protocol for a randomised crossover trial. Trials. 2016 Oct 24;17(1):516. doi: 10.1186/s13063-016-1649-x.

    PubMed 27776536

Questions about this trial

What is this clinical trial studying?

A study testing High glycemic index breakfast and Low glycemic index breakfast in people with Healthy, run by Fundacion para la Investigacion y Formacion en Ciencias de la Salud at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Augmentation index (time frame: Changes in augmentation index at 1 week, according to glycemic index of the breakfast). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02616276, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in